Abstract
Studies conducted between 1971 and 1975 showed that attenuated sporozoites can induce protection against human malaria. Three volunteers were protected against challenge with either a homologous or heterologous strain of Plasmodium falciparum after being exposed to a total of 440-987 X-irradiated mosquitos on 6-8 occasions over a period of 10-38 weeks. Protection lasted for at least 8 weeks, but not 16 weeks, after the last immunization with irradiated sporozoites. Another 7 volunteers were not protected against challenge with a homologous strain after exposure to a total of fewer than 200 irradiated mosquitos, infected with either P. falciparum or P. vivax, on 2-4 occasions over a period of 4-17 weeks. These studies provide an encouraging basis for pursuing the development of a sporozoite vaccine against human malaria.
Full text
PDF![13](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e14b/2393053/fb92bc458509/bullwho00058-0015.png)
![14](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e14b/2393053/70540ea81a45/bullwho00058-0016.png)
![15](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e14b/2393053/c51974ae485c/bullwho00058-0017.png)
![16](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e14b/2393053/5f9fdd7aa83e/bullwho00058-0018.png)